COVID-19 and reactions in the Norwegian population

Publications 2025

Hansen BT, Dahl J, Greve-Isdahl M, Winje BA, Rydland KM, Campbell S, Pay ASD, Michelsen TM, Meijerink H (2025)
Low and inequitable influenza and COVID-19 vaccination coverage among pregnant women in Norway: Nationwide population-based cohort study
Vaccine, 61, 127386 (in press)
DOI 10.1016/j.vaccine.2025.127386, PubMed 40517499

Ueland T, Cox RJ, Michelsen AE, Fjelltveit EB, Otterdal K, Dahl T, Zhou F, Elyanow R, Aukrust P, Blomberg B, Halvorsen BE, Langeland N (2025)
Markers of T cell activation and exhaustion in plasma are associated with persistent symptoms up to 18 months following mild SARS-CoV-2 infection
Front Immunol, 16, 1578208
DOI 10.3389/fimmu.2025.1578208, PubMed 40519925

Granerud BK, Kaarbø M, Al-Baldawi H, The Norwegian Sars-CoV-Study Group Investigators, Otterdal K, Halvorsen B, Lind A, Rayner S, Holter JC, Dudman S (2025)
Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma-Is There a Difference?
Viruses, 17 (6)
DOI 10.3390/v17060772, PubMed 40573363